InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.

Patients who got myocarditis post-vaccination were much less likely to be rehospitalized or suffer other cardiovascular complications.

yocarditis is a heart condition where the muscle of the heart is inflamed, which can cause chest pain and shortness of breath. In severe cases, myocarditis can weaken the heart, leading to blood clots that can cause strokes or heart attacks. This condition is a rare, but serious side effect of mRNA vaccines for COVID-19, particularly for young men. It’s also associated with COVID-19 infections.

A new report published in the Journal of the American Medical Association studied the prognosis for patients who were hospitalized for myocarditis after a vaccination, myocarditis after COVID-19 infection and conventional cases of myocarditis. Patients with these conditions were monitored for 18 months after initial hospitalization.

The researchers behind the study found that patients who got myocarditis post-vaccination were much less likely to be rehospitalized or suffer other cardiovascular complications than patients who got the condition from a COVID-19 infection. Complications for those patients were seen at about the same rate as those seen for patients with conventional myocarditis. These findings are consistent with previous, shorter-term studies that also found that post-vaccine myocarditis is less severe than myocarditis caused by COVID-19 infection itself.

Based on their findings as well as past studies, the researchers concluded that post-vaccine myocarditis patients “have a lower frequency of cardiovascular complications” than........

© Forbes